Shire reports analysis examining emotional lability in children with ADHD taking Vyvanse
PHILADELPHIA -- November 12, 2009 -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc…
Nov 13, 2009